108 results
Keyword Alimta - Polvere Remove keyword
-
List item
Opinion/decision on a Paediatric investigation plan (PIP): Alimta, pemetrexed disodium
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: EMEA-000126-PIP01-07, Route(s) of administration: Intravenous use, Pharmaceutical form(s): Powder for concentrate for solution for infusion
Decision date: 24/02/2009, Last updated: 23/04/2009, Compliance check: XInvented name Alimta Active substance pemetrexed … for pemetrexed disodium (Alimta) (EMEA-000126-PIP01-07 … for pemetrexed disodium (Alimta) (EMEA-000126-PIP01-07 … -
List item
Human medicine European public assessment report (EPAR): Alimta
pemetrexed, Mesothelioma; Carcinoma, Non-Small-Cell Lung
Date of authorisation: 20/09/2004, Revision: 27, Authorised, Last updated: 03/05/2022Alimta Cancer Neoplasms Carcinoma … Alimta … Alimta EPAR Summary update for II … -
List item
Herceptin, Alimta and Remicade batches concerned by ongoing investigation
Last updated: 01/01/2015Herceptin, Alimta and Remicade batches concerned …
-
List item
Human medicine European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis)
pemetrexed diacid monohydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 18/01/2016, Revision: 12, Authorised, Last updated: 18/01/2023European Union (EU) called Alimta, but it is available in a … in a different form. While Alimta is available as a powder … as the reference medicine, Alimta. What are the benefits and … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Baxter
pemetrexed disodium heptahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 09/12/2022,
, Authorised, Last updated: 19/01/2023
authorised in the EU called Alimta. For more information on generic … with the reference medicine, Alimta, and do not need to be repeated … and to be bioequivalent to Alimta. Therefore, the Agency’s … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Accord
pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 18/01/2016,, Revision: 9, Authorised, Last updated: 03/11/2022
European Union (EU) called Alimta. Pemetrexed Accord contains … as the reference medicine, Alimta. What are the benefits and … shown to be comparable to Alimta. Therefore, the CHMP’s view … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Pfizer (previously Pemetrexed Hospira)
pemetrexed disodium, pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 19/11/2015,, Revision: 14, Authorised, Last updated: 21/09/2022
European Union (EU) called Alimta. Pemetrexed Hospira contains … as the reference medicine, Alimta. What are the benefits and … shown to be comparable to Alimta. Therefore, the CHMP’s view … -
List item
Human medicine European public assessment report (EPAR): Ciambra
pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 02/12/2015,, Revision: 6, Authorised, Last updated: 17/08/2022
European Union (EU) called Alimta. Ciambra contains the active … as the reference medicine, Alimta. What are the benefits and … shown to be comparable to Alimta. Therefore, the CHMP’s view … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed medac
pemetrexed, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 26/11/2015,, Revision: 8, Authorised, Last updated: 09/08/2022
European Union (EU) called Alimta. Pemetrexed medac contains … as the reference medicine, Alimta. What are the benefits and … shown to be comparable to Alimta. Therefore, the CHMP’s view … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Sandoz
pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 18/09/2015,, Revision: 7, Authorised, Last updated: 27/07/2022
European Union (EU) called Alimta. Pemetrexed Sandoz contains … as the reference medicine, Alimta. What are the benefits and … shown to be comparable to Alimta. Therefore, the CHMP’s view … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Fresenius Kabi
pemetrexed, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 22/07/2016,, Revision: 13, Authorised, Last updated: 27/07/2022
European Union (EU) called Alimta. Pemetrexed Fresenius Kabi … as the reference medicine, Alimta. What are the benefits and … shown to be comparable to Alimta. Therefore, the CHMP’s view … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Krka (updated)
pemetrexed disodium, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 22/05/2018,, Revision: 6, Authorised, Last updated: 22/02/2023
authorised in the EU called Alimta. How is Permetrexed Krka used … with the reference medicine, Alimta, and do not need to be repeated … shown to be comparable to Alimta. Therefore, the Agency’s … -
List item
News: Update on investigation by Italian authorities into the supply of stolen medicines
Last updated: 03/06/2014Herceptin, Remicade and Alimta) has identified two additional … that lists the batches of Alimta (pemetrexed), Avastin (bevacizumab … on 16 and 17 April 2014. Alimta: EPAR Avastin: EPAR Herceptin … -
List item
Press release: European Medicines Agency update on stolen vials of Herceptin
Last updated: 17/04/2014vials of two other medicines, Alimta (pemetrexed) and Remicade … of any tampered vials of Alimta or Remicade being distributed … H4180B01 and N1010B02. For Alimta, the following batch numbers … -
List item
Orphan designation: pemetrexed disodium for: Treatment of malignant mesothelioma
Date of designation: 17/09/2001, Withdrawn, Last updated: 06/05/2011Update: Pemetrexed disodium (Alimta) has been authorised in the … since 22 September 2004. Alimta in combination with cisplatin … mesothelioma. More information on Alimta can be found in the European … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 September 2011
CHMP, Last updated: 23/09/2011PDF icon application/pdf Alimta pemetrexed Eli Lilly Nederland … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,18-21 February 2008
CHMP, Last updated: 21/02/2008Alimta … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Lilly
pemetrexed, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 14/09/2015,, Revision: 7, Withdrawn, Last updated: 26/11/2021
is a generic medicine of Alimta. There are other generic medicinal … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Pfizer (previously known as Pemetrexed Hospira UK Limited)
pemetrexed ditromethamine, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 24/04/2017,, Revision: 7, Withdrawn, Last updated: 29/07/2021
is a generic medicine of Alimta. There are other generic medicinal … generic medicinal products of Alimta authorised and marketed … European Union (EU) called Alimta. For more information on … -
List item
Human medicine European public assessment report (EPAR): Cyramza
Ramucirumab, Stomach Neoplasms
Date of authorisation: 19/12/2014, Revision: 15, Authorised, Last updated: 13/12/2022 -
List item
Human medicine European public assessment report (EPAR): Xalkori
crizotinib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 23/10/2012, Revision: 33, Authorised, Last updated: 02/12/2022 -
List item
Human medicine European public assessment report (EPAR): Caprelsa (updated)
Vandetanib, Thyroid Neoplasms
Date of authorisation: 16/02/2012,
, Revision: 24, Authorised, Last updated: 09/03/2023
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2014
CHMP, Last updated: 25/04/2014Update on Herceptin, Alimta and Remicade … -
List item
Human medicine European public assessment report (EPAR): Jakavi
ruxolitinib (as phosphate), Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease
Date of authorisation: 23/08/2012, Revision: 27, Authorised, Last updated: 17/01/2023 -
List item
Human medicine European public assessment report (EPAR): Abraxane
paclitaxel, Breast Neoplasms; Pancreatic Neoplasms; Carcinoma, Non-Small-Cell Lung
Date of authorisation: 11/01/2008, Revision: 29, Authorised, Last updated: 13/05/2022